These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25716055)

  • 41. The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.
    An HS; Kim GB; Song MK; Lee SY; Kwon HW; Lee JW; Bae EJ
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):78. PubMed ID: 34078404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive factors of coronary aneurysm in Kawasaki disease--correlation between coronary arterial lesions and serum albumin, cholinesterase activity, prealbumin, retinol-binding protein and immature neutrophils.
    Nakano M
    Prog Clin Biol Res; 1987; 250():535-7. PubMed ID: 3423065
    [No Abstract]   [Full Text] [Related]  

  • 43. Overweight, obesity and coronary artery lesions among Kawasaki disease patients.
    Shi H; Weng F; Li C; Jin Z; Hu J; Chu M; Qiu H
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1604-1612. PubMed ID: 33812731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
    Ruan Y; Ye B; Zhao X
    Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.
    Nakamura Y; Yashiro M; Uehara R; Sadakane A; Chihara I; Aoyama Y; Kotani K; Yanagawa H
    J Epidemiol; 2010; 20(4):302-7. PubMed ID: 20530917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical spectrum of Kawasaki disease in infants.
    Tseng CF; Fu YC; Fu LS; Betau H; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):168-73. PubMed ID: 11458622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan.
    Hirata S; Nakamura Y; Yanagawa H
    Acta Paediatr; 2001 Jan; 90(1):40-4. PubMed ID: 11227331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac Valvular Lesions due to Kawasaki Disease: A Japanese Nationwide Survey.
    Tsuda E; Yashiro M; Nakamura Y
    J Pediatr; 2020 Mar; 218():78-84.e2. PubMed ID: 32089190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasma prealbumin and C-reactive protein predicts coronary artery lesions in children with Kawasaki disease].
    Zhang CY; Liu LL; Liao Y; DU JB; Jin HF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):207-10. PubMed ID: 23591338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.
    Nakamura Y; Yashiro M; Uehara R; Sadakane A; Tsuboi S; Aoyama Y; Kotani K; Tsogzolbaatar EO; Yanagawa H
    J Epidemiol; 2012; 22(3):216-21. PubMed ID: 22447211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time course of cardiac lesions due to Kawasaki disease in Japan: 22nd nationwide survey (2011-2012).
    Goto T; Sano T; Kojo T; Ae R; Aoyama Y; Makino N; Kotani K; Nakamura Y
    Pediatr Int; 2016 Dec; 58(12):1274-1276. PubMed ID: 27285479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Early diagnosis of Kawasaki disease complicated by coronary artery lesions].
    Hu XH; Xu SX; Luan Z
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):853-5. PubMed ID: 12919919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
    Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
    J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.
    Cheung YF; Ho MH; Tam SC; Yung TC
    Heart; 2004 Nov; 90(11):1281-5. PubMed ID: 15486121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan.
    Yanagawa H; Nakamura Y; Yashiro M; Ojima T; Tanihara S; Oki I; Zhang T
    Pediatrics; 1998 Dec; 102(6):E65. PubMed ID: 9832593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal Clusters of Kawasaki Disease Cases Share Distinct Phenotypes That Suggest Response to Diverse Triggers.
    Burns JC; DeHaan LL; Shimizu C; Bainto EV; Tremoulet AH; Cayan DR; Burney JA
    J Pediatr; 2021 Feb; 229():48-53.e1. PubMed ID: 32976897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one-year follow-up study.
    Oki I; Tanihara S; Ojima T; Nakamura Y; Yanagawa H
    Acta Paediatr; 2000 Dec; 89(12):1435-8. PubMed ID: 11195232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.